Shanxi Kangbao Biological Product Co., Ltd.

This study tested a new medicine called LP-98, given as multiple shots under the skin, in 40 adults with HIV who had not taken any HIV drugs before. The main goals were to check if the shots are safe and how they affect the virus and the body. The results will help decide if LP-9…

This early-stage study tested a new injectable drug, Lipovirtide, in 24 people with HIV who were not taking any other HIV medications. The main goal was to check if the drug is safe and how the body processes it. Researchers also looked at whether it could lower the amount of vir…

This early-stage study tested a single injection of a new drug called lipovirtide in 46 adults with HIV who had never taken antiviral medicine. The main goal was to see if the drug is safe and how the body processes it. This is a first step toward possibly finding a new treatment…

This study tested a new medicine called Lipovirtide, given together with standard HIV drugs, in 64 adults with HIV who had never been treated before. The goal was to see if the combination could safely lower the amount of virus in the blood to very low levels. Participants receiv…

This early-stage study tested a single injection of a new drug called LP-98 in 36 healthy adults to see if it is safe and how the body processes it. Participants were randomly assigned to receive either the drug or a placebo. The main goal was to check for side effects and measur…